[Foreign substances as indicators of liver function].

Schweiz Med Wochenschr Suppl

Published: November 1985

The need to use xenobiotics to quantify liver function is based on the fact that the serum levels of endogenous tracers (such as transaminases, alkaline phosphatase, bilirubin and bile acids) cannot be interpreted in pharmacokinetic terms, since information is lacking on volume of distribution and on rate of synthesis and of disposition. Methods are now available which allow practically non-invasive estimation of (minimal) hepatic perfusion by indocyanine green fractional clearance, of portosystemic shunt flow by finger pulse photometry following nitroglycerin administration, of microsomal capacity by the aminopyrine breath test (ABT) or caffeine clearance, and of cytosolic function by galactose elimination capacity (GEC). Assessment of inherited hydroxylation deficiency of the debrisoquine type is best performed with dextromethorphan, and of the acetylator phenotype with sulfadimidine. Recently, caffeine clearance in saliva has been studied extensively in this laboratory, and, on the basis of a constant relationship between caffeine concentrations in serum and saliva, overnight clearance measurements (requiring a saliva sample at bedtime and upon arising following a single oral dose of caffeine) have been shown to be closely related to ABT or GEC. This approach, which has been successfully used in children, may represent the first simple and innocuous test for quantifying of hepatic function in the pediatric age group. The clinical utility of these clearance tests is to assess severity of disease (or genetically determined impairment of function), thus yielding important clues to prognosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

caffeine clearance
8
clearance
5
[foreign substances
4
substances indicators
4
indicators liver
4
liver function]
4
function] xenobiotics
4
xenobiotics quantify
4
quantify liver
4
function
4

Similar Publications

Background: The monocarboxylate transporter 1 (MCT1) plays a crucial role in regulating lactate and pyruvate transport across cell membranes, which is essential for energy metabolism during exercise. The A1470T (rs1049434) polymorphism has been suggested to influence lactate transport, with the T (major) allele associated with greater transport efficiency. This study aimed to investigate the effect of the polymorphism on lactate and potassium (K) concentrations in response to resistance exercise (RE) following caffeine (CAF) ingestion.

View Article and Find Full Text PDF

Looking at the albumin-drug binding via partitioning in aqueous two-phase system.

Biochem Biophys Res Commun

January 2025

Cleveland Diagnostics, 3615 Superior Ave., Cleveland, OH, 44114, USA. Electronic address:

The partition coefficient of human serum albumin (HSA) was analyzed in the PEG600-Dex70, 0.15 M NaCl/KCl in 0.01 M Na/K phosphate buffer, pH 7.

View Article and Find Full Text PDF
Article Synopsis
  • A 20-year-old woman was hospitalized after consuming high doses of caffeine (18g) and mexiletine (3500mg), leading to severe hypotension, tachycardia, hypokalemia, and lactic acidosis.
  • She underwent multiple medical interventions, including mechanical ventilation, noradrenaline infusion, and hemodialysis (HD), as her condition worsened to pulseless ventricular tachycardia requiring VA-ECMO support.
  • The case highlighted that mexiletine may hinder caffeine clearance, complicating treatment; however, after HD, her drug levels decreased significantly, allowing successful recovery and weaning from life support within a few days.
View Article and Find Full Text PDF

Vatiquinone, a 15-lipoxygenase inhibitor, is in development for patients with Friedreich's ataxia. Physiologically based pharmacokinetic (PBPK) modeling addressed drug-drug interaction gaps without additional studies. A PBPK model (Simcyp Simulator version 21, full model) was developed using parameters obtained from in vitro studies, in silico estimation and optimization, and two clinical studies.

View Article and Find Full Text PDF
Article Synopsis
  • Cytokine release syndrome, often linked to T-cell therapies like talquetamab, causes an increase in interleukin-6 (IL-6), which might inhibit certain liver enzymes (cytochrome P450).
  • The study aimed to assess how elevated IL-6 affects the metabolism of other drugs by looking at both standard and extreme IL-6 levels after talquetamab treatment.
  • Results showed that while normal IL-6 levels had no significant impact on drug interactions, elevated IL-6 could moderately affect specific liver enzymes, with potential effects peaking 7 to 9 days after the start of treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!